Cyclin A2, Rho GTPases and EMT - Université de Montpellier Accéder directement au contenu
Article Dans Une Revue Small GTPases Année : 2012

Cyclin A2, Rho GTPases and EMT


Cell cycle regulators, such as cyclins, are often upregulated in many proliferative disorders, and Cyclin A2 is generally considered as a marker of aggressive cancers. Our recent work, which revealed decreased expression of Cyclin A2 upon metastasis of colorectal cancer, suggests a more complicated situation. Consistent with this, we identified a role for Cyclin A2, via RhoA, in regulation of the actin cytoskeleton and the control of cell invasion. Cyclin A2 also regulates spindle orientation which, when misoriented, could disrupt cell polarity and favor cancer cell detachment from the tumor as part of a transforming process, such as epithelial to mesenchymal transition (EMT). During EMT, cells undergo morphological and molecular changes toward a mesenchymal phenotype. Upregulation, or increased activity of some Rho GTPases, such as Cdc42, Rac1 or RhoC, increases the invasive potential of these cells. This correlates with the inverse relationship between RhoA and RhoC activities we observed in an epithelial cell type. Altogether, these observations raise the possibility that Cyclin A2 is instrumental in preventing EMT and therefore cancers of epithelial tissues.

Dates et versions

hal-03040941 , version 1 (04-12-2020)



Nawal Bendris, Nikola Arsic, Bénédicte Lemmers, Jean Marie Blanchard. Cyclin A2, Rho GTPases and EMT. Small GTPases, 2012, 3 (4), pp.225-228. ⟨10.4161/sgtp.20791⟩. ⟨hal-03040941⟩
36 Consultations
0 Téléchargements



Gmail Facebook X LinkedIn More